Fund Information
Type of Scheme | Large & Mid Cap Fund - An open ended equity scheme investing in both large cap and mid cap stocks |
Investment Objective | The investment objective of the scheme is to generate income and capital appreciation from a portfolio primarily investing in Indian equities and equity related securities of large cap and mid cap companies at the time of investment. From time to time, the fund manager may also seek participation in other Indian equity and equity related securities to achieve optimal Portfolio construction. The Scheme does not guarantee or assure any returns |
Fund Manager** | Mr. Neelesh Surana, |
Allotment Date | 09th July, 2010 |
Benchmark Index | Nifty Large Midcap 250 (TRI) |
Minimum Investment | Fresh lumpsum subscription/switch-in to all the Plans & Options of Mirae Asset Emerging Bluechip Fundthrough any mode including Stock Exchange platform has been temporarily suspended with effect from October 25, 2016 |
Systematic Investment | Fresh Registration through the Systematic Route i.e. Systematic Investment Plan (SIP) shall be allowed for a maximum of upto ₹ 25,000/- aggregated at primary holder PAN through monthly or quarterly mode cumulatively aggregated across all available SIP Dates from 1st to 28th of the month. The changes are effective from July 01, 2019. For more details please refer to the addendum dated May 31, 2019. |
Load Structure | Entry load: NA |
Plans Available | Regular Plan and Direct Plan |
Options Available | Growth Option and Dividend Option (Payout & Re-investment) |
Monthly Average AUM | 11,145.15 |
Net AUM ( ₹ Cr.) | 11,315.61 |
Monthly Avg.Expense Ratio | Regular Plan:1.86% |
ANY DATE SIP provides one of the better investment experiences by allowing the investor to choose any investment date of the month (i.e., from 1st to 28th) depending upon the investors' expense and income flow. | |
**For experience of Fund Managers Click Here |
Net Asset Value (NAV)
NAV: | Direct Plan | Regular Plan |
Growth Option | ₹ 62.142 | ₹ 57.915 |
Dividend Option | ₹ 47.951 | ₹ 29.353 |
Ratios@ (Annualised)
Volatility | 22.38% |
Beta: | 0.94 |
R Squared | 0.98 |
Sharpe Ratio#: | 0.16 |
Information Ratio | 1.14 |
Portfolio Turnover Ratio^ | 0.84 times |
@The Volatility, Beta, R Squared, Sharpe Ratio & Information Ratio are calculated on returns from last three years Monthly data points. # Risk free rate: FBIL OVERNIGHT MIBOR as on 31st August 2020.^Basis last rolling 12 months. |
Portfolio
Portfolio Holdings | % Allocation |
Banks | |
HDFC Bank Ltd | 7.09% |
ICICI Bank Ltd | 5.54% |
Axis Bank Ltd | 4.17% |
State Bank of India | 2.74% |
Kotak Mahindra Bank Ltd | 1.05% |
IndusInd Bank Ltd | 0.46% |
Consumer Non Durables | |
Emami Ltd | 2.28% |
ITC Ltd | 2.09% |
Kansai Nerolac Paints Ltd | 1.98% |
Hindustan Unilever Ltd | 1.71% |
Tata Consumer Products Ltd | 1.48% |
Dabur India Ltd | 1.33% |
Jyothy Labs Ltd | 0.82% |
Finance | |
Max Financial Services Ltd | 2.77% |
Cholamandalam Investment and Finance Company Ltd | 1.65% |
Indian Energy Exchange Ltd | 1.51% |
Power Finance Corporation Ltd | 1.43% |
HDFC Life Insurance Company Ltd | 1.32% |
SBI Life Insurance Company Ltd | 0.76% |
SBI Cards and Payment Services Ltd | 0.25% |
Software | |
Infosys Ltd | 4.20% |
Tata Consultancy Services Ltd | 2.91% |
MindTree Ltd | 2.46% |
Petroleum Products | |
Reliance Industries Ltd* | 4.89% |
Bharat Petroleum Corporation Ltd | 1.95% |
Hindustan Petroleum Corporation Ltd | 1.30% |
Pharmaceuticals | |
Natco Pharma Ltd | 1.48% |
Ajanta Pharma Ltd | 1.46% |
Sun Pharmaceutical Industries Ltd | 1.36% |
IPCA Laboratories Ltd | 1.26% |
Lupin Ltd | 0.80% |
Syngene International Ltd | 0.59% |
Torrent Pharmaceuticals Ltd | 0.16% |
Auto | |
Maruti Suzuki India Ltd | 2.13% |
Ashok Leyland Ltd | 1.57% |
TVS Motor Company Ltd | 1.46% |
Consumer Durables | |
Voltas Ltd | 2.60% |
Havells India Ltd | 1.19% |
Titan Company Ltd | 0.29% |
Telecom - Services | |
Bharti Airtel Ltd | 3.37% |
Auto Ancillaries | |
Balkrishna Industries Ltd | 1.97% |
CEAT Ltd | 1.25% |
Industrial Products | |
SRF Ltd | 1.64% |
SKF India Ltd | 1.31% |
Construction Project | |
Larsen & Toubro Ltd | 2.36% |
Gas | |
Gujarat State Petronet Ltd | 1.91% |
Power | |
NTPC Ltd | 1.58% |
Chemicals | |
Vinati Organics Ltd | 1.27% |
Tata Chemicals Ltd | 0.26% |
Industrial Capital Goods | |
Bharat Electronics Ltd | 1.49% |
Cement | |
JK Cement Ltd | 1.19% |
Textile Products | |
Page Industries Ltd | 0.77% |
Healthcare Services | |
Dr. Lal Path Labs Ltd | 0.77% |
Retailing | |
Avenue Supermarts Ltd | 0.48% |
Aditya Birla Fashion and Retail Ltd | 0.20% |
Ferrous Metals | |
Tata Steel Ltd | 0.65% |
Transportation | |
Gateway Distriparks Ltd | 0.49% |
Non - Ferrous Metals | |
National Aluminium Company Ltd | 0.08% |
Equity Holding Total | 99.51% |
Cash & Other Receivables | 0.49% |
Total | 100.00% |
*Includes "Partly Paid Shares"
Changes in Stock Position
New Position Bought |
Stock |
Software |
Info Edge (India) Limited |
Finance |
Muthoot Finance Limited |
Positions Increased |
Stock |
Auto Ancillaries |
CEAT Limited |
Banks |
HDFC Bank Limited |
ICICI Bank Limited |
Consumer Non Durables |
Emami Limited |
Hindustan Unilever Limited |
ITC Limited |
Tata Consumer Products Limited |
Healthcare Services |
Dr. Lal Path Labs Limited |
Petroleum Products |
Bharat Petroleum Corporation Limited |
Reliance Industries Limited |
Pharmaceuticals |
IPCA Laboratories Limited |
Lupin Limited |
Natco Pharma Limited |
Software |
Infosys Limited |
Telecom - Services |
Bharti Airtel Limited |
Positions Decreased |
Stock |
Auto |
TVS Motor Company Limited |
Banks |
IndusInd Bank Limited |
Kotak Mahindra Bank Limited |
Chemicals |
Tata Chemicals Limited |
Construction Project |
Larsen & Toubro Limited |
Consumer Durables |
Havells India Limited |
Consumer Non Durables |
Tata Consumer Products Limited |
Finance |
Cholamandalam Investment and Finance Company Limited |
Indian Energy Exchange Limited |
Power Finance Corporation Limited |
SBI Cards and Payment Services Limited |
Industrial Capital Goods |
Bharat Electronics Limited |
Petroleum Products |
Reliance Industries Limited |
Pharmaceuticals |
Sun Pharmaceutical Industries Limited |
Syngene International Limited |
Power |
NTPC Limited |
Dividend History
Record Date | Dividend (₹) | Face Value (₹) | Cum Nav (₹) |
05-Jan-16 | 2.00 per Unit | 10 | 24.495 |
20-Jul-16 | 2.00 per Unit | 10 | 24.292 |
24-Jul-17 | 2.50 per Unit | 10 | 28.233 |
06-Dec-18 | 2.50per Unit | 10 | 29.737 |
16-Jan-20 | 1.70 per Unit | 10 | 31.950 |
Past Performance may or may not be sustained in future.Pursuant to payment of dividend the NAV of the dividendoption of the scheme will fall to the extent of payout andstatutory levy (if any).Dividend history is for MAEBF- Regular Plan - Dividend Option
Fund Performance
Allocation - Top 10 Sectors^
Performance Report
Returns (%) | ||||
1 Yr | 3 Yrs | 5 Yrs | SI | |
MAEBF | 12.46 | 7.28 | 13.81 | 18.88 |
Scheme Benchmark* | 8.28 | 3.46 | 9.11 | 10.01 |
Additional Benchmark** | 4.60 | 8.04 | 9.39 | 9.43 |
NAV as on 31st August, 2020 | 57.915 | |||
Index Value (31st August, 2020) | Index Value of Scheme benchmark is 7267.70 and S&P BSE Sensex (TRI) is s 56932.37 | |||
Allotment Date | 9th July, 2010 | |||
Scheme Benchmark | *Nifty Large Midcap 250 (TRI) | |||
Additional Benchmark | **S&P BSE Sensex (TRI) |
Note:1. Different Plans under the scheme has different expense structure. The reference and details provided herein are of Regular Plan - Growth Option
2. Fund manager : Mr. Neelesh Surana managing the scheme since 9th July, 2010 & Mr. Ankit Jain since 31st ,January 2019)
SIP
Period | Total Amount Invested | Mkt Value as on 31-August-2020 |
SIP | 1,210,000 | 3,346,552 |
10 Yrs | 1,200,000 | 3,290,870 |
7 Yrs | 840,000 | 1,491,702 |
5 Yrs | 600,000 | 804,143 |
3 Yrs | 360,000 | 410,140 |
1 Yr | 120,000 | 133,883 |
Returns (%) | Period | |||||
SI | 10yrs | 7yrs | 5yrs | 3yrs | 1yr | |
Fund Return& (%) | 19.14 | 19.15 | 16.11 | 11.66 | 8.65 | 22.14 |
Benchmark Return& (%) | 11.05 | 11.08 | 9.32 | 6.88 | 3.41 | 18.44 |
Add. Benchmark Return& (%) | 10.03 | 10.05 | 9.15 | 8.96 | 6.23 | 13.78 |
& The SIP returns are calculated by XIRR approach assuming investment of ₹ 10,000/- on the 1st working day of every month.
Riskometer
This product is suitable for investors who are seeking*
• Long term capital appreciation
• Large & Midcap fund investing atleast 35% in largecap stock & atleast 35% in midcap stocks
• Degree of risk – MODERATELY HIGH
![MIRAE ASSET INDIA EQUITY FUND - (MAIEF) (3) MIRAE ASSET INDIA EQUITY FUND - (MAIEF) (3)](https://i0.wp.com/www.miraeassetmf.co.in/Performance-Report/blue-chip-risko.png)
*Investors should consult their financial advisers if they are not clear about the suitability of the product.
Past Performance may or may not be sustained in future.
Note : For computation of since inception returns (%) the allotment NAV has been taken as ₹ 10.00. The performance of other funds managed by the same fund managers are given in the respective page of the schemes